| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biological Sciences,1 Department of Biochemistry, University of Iowa, Iowa City, Iowa2
Received 26 June 2004/ Accepted 21 September 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
and ypd1
mutants, as does overexpression of the HOG1 phosphatase, PTP2 (46). The SKN7 gene was identified in a number of genetic screens, including one for high-copy suppressors of a mutation in KRE9 affecting cell wall ß-glucan assembly and another for increased sensitivity to oxidative stress (30). A third screen in which SKN7 was identified was for high-copy suppressors of the lethality associated with loss of the G1 transcription factors SBF and MBF (43). Finally, we identified SKN7 in a screen for high-copy activators of a SLN1-dependent reporter gene (33). The variety of screens in which SKN7 emerges presumably reflects the broad functional spectrum of genes that are regulated by this transcription factor-coupled response regulator. The various phenotypes of skn7 mutants can be divided into two categories based on whether the conserved phosphoaccepting aspartate (D427) in its receiver domain is required for complementation. The oxidative stress phenotype of skn7 mutants does not require D427, for example (33, 42), whereas suppression of a temperature-sensitive pkc1 mutant, a phenotype that probes the cell wall-related function of Skn7p, does require the presence of D427, as does the cell cycle-related function (43) and activation of SLN1-dependent reporters (2, 14).
Skn7p has an HSF-like helix-turn-helix DNA-binding domain and has been reported to bind to the upstream regulatory region of TRX2 (42), SSA1 (50), and OCH1 (34). Just distal to the DNA-binding domain of Skn7p is a coiled-coil (cc) domain involved in protein interactions. Skn7p has been shown to self-associate, as well as to interact with a number of proteins, including the stress transcription factors, Hsf1p (50) and Yap1p (42); the cell cycle transcription factor, Mbp1p (11, 43); and the calcium responsive transcription factor, Crz1p (64). An interaction with the Rho1 GTPase has also been reported (1). The coiled-coil region of Skn7p is presumed to be required for each of these interactions as its deletion eliminates complementation of nearly all tested phenotypes (1).
An important regulatory mechanism in many signal transduction pathways is the subcellular localization or compartmentalization of signaling molecules. For example, in the osmotic stress MAP kinase pathway, the MAP kinase, Hog1p, which is predominantly cytoplasmic in unstressed cells, rapidly accumulates in the nucleus in response to increased osmolarity (53). MAP kinases, including Hog1p, lack classical import signals, and nuclear accumulation of Hog1p depends on its phosphorylation by the cytoplasmic MEK, Pbs2 (21, 53), and the Ptp2 protein, which may serve as a nuclear anchor (41). Like Hog1p, the Msn2p and Msn4p transcription factors that are involved in HOG1-dependent and HOG1-independent stress responses become nuclear after exposure of cells to stress (23). Although Hog1p specifically localizes in response to osmotic stress, the Msn2 and Msn4 proteins become nuclear after a variety of stress treatments (23). Like Hog1p, Msn2p, and Msn4p possess no apparent nuclear localization signal (NLS). Rather, the presence of a 300-amino-acid (aa) domain was found to be crucial for cytoplasmic localization under nonstress conditions (23), suggesting a localization mechanism based on shuttling and cytoplasmic anchoring. The oxidative stress transcription factor Yap1p also moves to the nucleus in response to stress (31, 65). Cysteine residues in the C-terminal tail are required for the cytoplasmic localization of Yap1p in unstressed cells, and removal of the tail results in constitutive nuclear localization.
The subcellular localization of the yeast two-component proteins involved in osmotic stress has recently been investigated. Sln1p was found on the plasma membrane both before and after osmotic shock (36, 52). Ssk1p is cytoplasmic (36), and the Skn7p transcription factor is nuclear (12, 50). No changes in Skn7p localization have been observed in response to either oxidative or osmotic stress. Instead, the phosphorelay molecule Ypd1p shuttles in and out of the nucleus to phosphorylate the cytoplasmic response regulator, Ssk1p, and the nuclear response regulator, Skn7p, as needed (36).
Further insight into the localization and compartmentalization of two-component signal transduction molecules has emerged with our recent observation that the Mog1 protein, known to be involved in nucleocytoplasmic macromolecule transport in S. cerevisiae, interacts with molecules of the SLN1-SKN7 signal transduction pathway. In strains lacking MOG1 both NLS-dependent and NLS-independent protein import pathways are abolished at high temperature, although mRNA export is normal (45). MOG1 was initially identified in a screen for suppressors of a temperature-sensitive mutations in GSP1, which encodes a homolog of mammalian Ran (45), a Ras-like GTP-binding protein that, together with its nucleotide exchanger, RCC1, has been implicated in the control of protein movement into the nucleus and cytoplasmic accumulation of mRNA. Like its mammalian counterpart, Gsp1p cycles between the GTP and GDP bound forms as it shuttles between cytoplasm and nucleus. Hydrolysis of GTP is necessary for proper import of proteins into the nucleus and appearance of poly(A)+ RNA in the cytoplasm. Although the precise function of Mog1p in the Ran cycle is not yet known, it has been proposed that Mog1p is needed for maintaining the nuclear biased gradient of Gsp1p (57).
We show here that Mog1p physically interacts with Ypd1p and Skn7p, as well as Sln1p. In addition, strains lacking Mog1p have phenotypes that suggest defects in SLN1-SKN7 signal transduction. Based on the known function of Mog1p in nucleocytoplasmic transport, we propose a model in which Mog1p plays one role in moving Skn7p to the nucleus and a second role in ensuring Skn7p activation in response to stimulation of the SLN1 pathway.
| MATERIALS AND METHODS |
|---|
|
|
|---|
::HIS3 fragment was amplified by using pRS313 as a template and forward primer MOG1-9F::pRS (5'-GGTTTGCATATGAAGATTGAAAAGGCTTCTCATATTTCACAActgtgcggtatttcacaccg; lowercase letters are pRS vector sequences) and reverse primer MOG1+607R::pRS (5'-GCAACAATTGGTAAACAGCATGACATCTTGCAGGCAACTCTTTagattgtactgagagtgcac). The djp1
::HIS3 fragment was amplified by using the forward primer DJP116F::pRS (5'-GCATTATACAAAAGATATGGTTGTTGATACTGAGTATTACGActgtgcggtatttcacaccg) and the reverse primer DJP1+1274R::pRS (5'-GCTTCTGCTACAAGTTCTTCAAAGATCTGTGCCTCTTCTTagattgtactgagagtgcac). The replacement was confirmed by genomic PCR and subsequent restriction analyses of the amplified fragments. Deletion of the MOG1 ORF in the S288C strain background did not have the previously reported temperature-sensitive phenotype (45). Since earlier studies showed that the temperature-sensitive phenotype of mog1 mutants is tightly associated with its nucleocytoplasmic transport defect (45), the MOG1 disruption was recreated in strain YPH499 (Stratagene) as previously reported (45). As expected, the MOG1 disruption in the YPH499 background was temperature sensitive for viability (Fig. 2).
|
|
Media. All media were prepared as described by Sherman et al. (54) and included synthetic complete medium (SC) lacking one or more specific amino acids (e.g., SChistidine) and rich medium (yeast extract-peptone-dextrose [YPD]). The growth temperature for yeast culture was 28°C unless otherwise indicated. Yeast transformation was performed by a modified lithium acetate method (22, 28). Plasmids were recovered from yeast by using a Zymoprep Miniprep kit (Zymo Research).
Plating assays. Log-phase cells were spotted onto various media after serial 10-fold dilutions. Osmotic stress sensitivity was tested on YPD plates containing 0.9 M NaCl or 1.5 M sorbitol. Responsiveness to oxidative stress was examined by growing yeast for 2 to 3 days on YPD medium containing 0.5 mM t-butyl-hydroperoxide (Sigma). Resistance to hygromycin B (Boehringer Mannheim) was tested at concentrations of 50 to 80 µg/ml in YPD medium. All drug sensitivity assays were carried out at 28°C.
Plasmids. Plasmids used in the present study are summarized in Table 2. Their construction is summarized below.
|
Plasmids for protein association analysis. Hemagglutinin (HA) fusion constructs were created by using the UASADH1-Gal4 DBD-HA yeast two-hybrid vector, pAS1-CYH2 (19).
To construct the HA-YPD1 fusion the BamHI-SalI fragment of YPD1 was subcloned from the GST-YPD1 fusion construct pCLM655 (33) into pAS1-CYH2 to create pJL1298.
The HA-SKN7 fusions were constructed by cloning the BamHI-SalI double-digested PCR product amplified with the primers SKN7-1F (5'-GGGATCCCATATGAGCTTTTCCACCATAAA-3') and SKN7+1882R (5'-GGGTTGTCGACGCAAGGCTATTTGTAAA-3') and the plasmids pSL232, pCLM699, pCLM700 (33), and pSL1129 as templates into pAS1-CYH2 to create pJL1290 (wild-type D427), pJL1294 (D427N), and pJL1292 (D427E), and pJL1296 (
DBD; lacking aa 27 to 237), respectively. pJL1306 is a pAS1-CYH2 plasmid carrying a BamHI-HincII fragment (aa 425 to 712) from pSSK1223 (a gift of H. Saito) that includes the receiver domain of Ssk1p.
pJL1286 carries a fragment of SLN1 receiver domain (aa 1068 to 1220) inserted into EcoRI-BamHI-digested pAS1-CYH2.
Glutathione S-transferase (GST) fusions of MOG1 and DJP1 were constructed by subcloning the EcoRI-SalI fragment of two-hybrid library clones containing MOG1 or DJP1 into pGEX-4T (Pharmacia). pJL1243 has a MOG1 insert (aa 78 to 218) derived from the library clone, pFL64-411, and pJL1244 has a DJP1 insert (aa 65 to 432) derived from the library clone, pFL99-12. For expressing full-length Mog1p in bacteria, MOG1 (+3 to +758) was PCR amplified, digested with BamHI and NotI, and cloned into pGEX-4T.
GFP fusion plasmids. A 2µm green fluorescent protein (GFP)-SKN7 plasmid was constructed in three steps. Plasmid pSL268 (pRS425-SKN7) was modified to eliminate the polylinker between SpeI and HindIII, generating pJL1362. BamHI and HindIII sites were then engineered in pJL1362 just beyond the translation initiation site of SKN7, and SpeI and HindIII sites were engineered at the stop codon of the SKN7 ORF. Outward PCR with the primers SKN7+1870F (5'-GCGAAGCTTAGATCTTAATACTAGTAATTTTACAAATAGCCTTGC-3')and SKN7+1R.HindIII-BamHI (5'-GCTAAGCTTGGATCCCATAGTGGATATCAAAAGTA-3') generated a 9.2-kb PCR product that was then digested with HindIII and self-ligated to create the 2µm plasmid, pJL1361, in which the SKN7 ORF was replaced by a BamHI-SpeI-HindIII polylinker. A UASSKN7-GFP control plasmid, pJL1363, was obtained by cloning a 0.72-kb PCR-derived GFP (S65T, F64L) fragment into pJL1361 via HindIII and BglII sites.
The high-copy (2µm) GFP-SKN7 fusion construct, pJL1380, was generated by cloning a 1.9-kb PCR fragment containing the SKN7 ORF amplified with the primers SKN7-1F.BamHI-NdeI (5'-GGGATCCCATATGAGCTTTTCCACCATAAA-3') and SKN7+1866R.HindIII-SpeI (5'-CGGAACTAGTGAAGCTTTGATAGCTGGTTTTCTTG-3') into the BamHI and SpeI sites in pJL1363. Plasmids encoding GFP fusion with truncated Skn7 protein were constructed by fusing BamHI-SalI-digested PCR fragments of SKN7, including aa 1 to 307, aa 217 to 499, or aa 370 to 622 behind GFP in pJL1363 to create pJL1364, pJL1365, and pJL1366, respectively.
Two-hybrid screen and assay. Two-hybrid analysis was performed in the yeast strain PJ69-4A according to the method of James et al. (29). pWT1111 contains the cytoplasmic portion of SLN1 (aa 356 to 1220) fused to the HA-tagged DNA-binding domain of pAS1-CYH2 (19, 60) and was used as the bait to screen an activation domain pGAD-C1 library (generously provided by Philip James) by cotransformation of PJ69-4A with pWT1111 and the pGAD library. His+ colonies were patched and replica plated onto medium containing 1 mM 3-aminotriazole (3-AT) and separately onto SCAde medium and medium containing 150 µg of X-Gal (5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside)/ml. Strong interactors were further tested on SCHis plates containing 3-AT at concentrations up to 25 mM. Plasmids rescued from Ade+, 3-ATR, X-Gal+ candidates were subjected to DNA sequencing to identify the insert.
Northern hybridization analysis.
Log-phase cultures grown at 27°C were harvested and stored at 80°C. RNA samples were extracted by using the hot acidic phenol method (4). mRNA was isolated by using the poly(A)+ RNA purification kit (Promega). One-tenth of each mRNA sample was loaded onto denaturing agarose gel (1.2%). Hybridization with [
-32P]dATP-labeled probes (Prime-It II Kit; Stratagene) was carried out in PerfectHyb solution (Sigma) at 68°C overnight. Quantitation was performed by phosphorimaging analysis. All bands were normalized to levels of PGK1.
Fluorescence microscopy. Log-phase cultures expressing GFP fusions were fixed in 70% ethanol, washed and resuspended in phosphate-buffered saline (PBS), and stained with 0.1 µg of DAPI (4',6'-diamidino-2-phenylindole; Sigma)/ml to visualize nuclei. Cells were observed with a Leica DM RBE microscope and a Leica x100 PL Fluotar 1.3 NA objective lens. Fluorescence images were captured by using a Photonic Science digital charge-coupled device camera system. Images were processed by using IP-LAB Spectrum software and edited in Adobe Photoshop.
Protein extraction and Western analysis. Strains were grown in selective medium with 2% glucose or in 2% raffinose. For galactose induction, 4% galactose was added to log-phase cultures for 3 h. Cell pellets were washed in 10 mM Tris-HCl (pH 7.5)-50 mM EDTA and then in coimmunoprecipitation buffer (50 mM Tris-HCl [pH 7.6], 10 mM MgCl2, 140 mM NaCl, 0.1% Triton X-100, 5 mM EDTA, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride, plus protease inhibitors) prior to storage at 80oC. Cells were disrupted by vortexing in the presence of 425- to 600-µm glass beads (Sigma). Lysates were cleared by centrifugation and stored at 20°C. Protein concentrations were determined by Bio-Rad Microassay. Expression of the test proteins were examined by immunoblot analysis with specific primary antibodies, followed by horseradish peroxidase-conjugated anti-immunoglobulin G secondary antibody. Immune complexes were visualized by enhanced chemiluminescence (Amersham Corp.).
Expression and purification of GST-tagged MOG1 and DJP1 fusion proteins. Cultures (0.6 liter) of Escherichia coli BL21-DE3-STAR (Invitrogen) containing GST fusion plasmids were induced with 0.2 mM IPTG (isopropyl-ß-D-thiogalactopyranoside) for 3 h. Cell pellets were store at 80°C and subsequently resuspended in 30 ml of buffer B (33, 48) containing 1% Triton X-100 and protease inhibitors. After sonication and centrifugation, lysates were incubated with 3 to 4 ml of washed 50% glutathione-Sepharose slurry (Amersham) at 4°C for 5 to 12 h. Beads were removed by centrifugation, washed three times in 20 ml of buffer B, washed twice in 10 ml of buffer C (33, 48), resuspended in 5 ml of buffer C, and stored at 20°C. Purified proteins were visualized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on gels stained with Coomassie blue.
In vitro protein coprecipitation assay. A total of 0.2 to 0.5 mg of total yeast protein was added to 0.5 ml of ice-cold protein-binding buffer (coimmunoprecipitation buffer with 1% bovine serum albumin), and aggregates were removed by centrifugation. Bead-bound GST fusion proteins were added, and the binding reactions were rocked on ice for 4 to 12 h. Beads were washed twice in ice-cold PBS, twice in coimmunoprecipitation buffer, three times in PBS-0.1% Tween 20, and three times in PBS-0.2% Tween 20, with 5-min room temperature incubations between each wash. Samples were then resuspended in loading sample buffer (32), boiled, and separated on SDS-12% PAGE gels. Prior to immunoblot analysis, proteins were visualized by Ponceau S (Sigma) staining to ensure the presence of similar amounts of GST fusions.
Phosphotransfer assays. Protein expression and glutathione affinity purification for Sln1-HK, Sln1-R1, Ypd1p, and Skn7p were performed as described previously (3, 33). When necessary, GST fusion proteins were solubilized by elution with glutathione or by thrombin cleavage and then dialyzed in storage buffer (50 mM Tris-HCl [pH 7.6], 50 mM KCl, 5 mM MgCl2, 0.1% ß-mercaptoethanol, 30% glycerol). Full-length His10-Skn7 protein was purified by using a His-Bind purification kit (Novagen). Phosphotransfer assays were performed as described previously (33, 48) by filtration-based separation of bead-bound phosphorylated phospho-donor from soluble phosphorylated phospho-acceptor. The purified, soluble, phosphorylated phospho-acceptor was then used as the donor in examining downstream phosphorelay reactions. To examine the effect of Mog1p on phosphotransfer steps, Mog1p was purified from bead-bound GST-Mog1p by thrombin cleavage. In each transfer step Mog1p was mixed with radiolabeled phospho-donor prior to the addition of unphosphorylated acceptor. In reactions lacking Mog1p, storage buffer was added to the same volume. Aliquots were removed from the phosphotransfer reactions at indicated time points. Samples were subjected to SDS-PAGE electrophoresis and radiolabeled protein species were visualized by phosphorimaging analysis.
Electrophoretic mobility shift assay. Preparation of yeast protein extracts and the mobility shift assay were carried out as described previously (34) with minor modifications. Binding reactions consisted of 5 µg of yeast protein extract, 1 µg of poly(dI-dC) (Boehringer Mannheim), and 0.5 to 1 ng (5 to 20 counts per minute) of probe in electrophoretic mobility shift assay buffer (25 mM Tris-HCl [pH 7.5], 50 mM NaCl, 7 mM MgCl2, 2 mM EDTA, 10% glycerol, 0.5 mg of CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate}/ml). Reactions were incubated at 25°C for 20 min before electrophoresis in 4% polyacrylamide gel in cool 0.5x Tris-borate-EDTA buffer (45 mM Tris, 1 mM EDTA, 44.5 mM boric acid) at 200 V for 2 to 3 h. In supershift assays, binding reactions were subsequently incubated with antibody for 30 min and complexes were resolved by electrophoresis. Electrophoretic mobility shift experiments were routinely repeated four to six times with extract sets prepared on different days. Representative gels are shown.
| RESULTS |
|---|
|
|
|---|
R): aa 356 to 1077].
|
-1,6-mannosyl-transferase involved in N glycosylation (34), and NCA3, a member of the "SUN" family of proteins whose products appear to have dual cell wall and mitochondrial functions and localization (62). Levels of OCH1 and NCA3 expression are increased by the sln1* mutation that activates the SLN1-SKN7 pathway (Fig. 2), and the increase is dependent on the phospho-accepting aspartate, D427 of SKN7 (34). To determine whether MOG1 or DJP1 play a role in modulating SLN1-SKN7 pathway signaling, sln1* activation of NCA3 and OCH1 was examined in mog1
and djp1
strains. As expected, NCA3 and OCH1 levels were increased three- to fivefold by the sln1* activating mutation in MOG1+ strains (Fig. 2). In the absence of MOG1, however, activation of NCA3 by sln1* was eliminated. The sln1*/SLN1+ ratio was 4.97 in a MOG1+ strain and 1.38 in the mog1
strain. Activation of OCH1 by sln1* was also reduced, with the sln1*/SLN1+ ratio going from 3.46 in the MOG1+ strain to 2.45 in the mog1
strain. Although less dramatic a change than for NCA3, this difference in OCH1 levels due to the absence of MOG1 is reproducible and statistically significant (Student t test; P = 0.004; t = 4.4). The difference in magnitude of the effect on NCA3 versus OCH1 may reflect differences in the Skn7p binding site in the two genes. The effects of mog1 deletion on NCA3 and OCH1 expression in a sln1* strain (but not in the SLN1+ strain, Fig. 2) suggest that SLN1-SKN7 pathway activation depends on MOG1. In contrast to the effect of a mog1 deletion, deletion of DJP1 had no effect on sln1* activation (data not shown). The absence of an effect of the djp1 deletion on SLN1-SKN7-dependent pathway activity was taken to indicate that the Djp1p interaction with Sln1p was unlikely to be physiologically meaningful and DJP1 was not pursued further.
We previously found that resistance to hygromycin B depends on SLN1-SKN7 pathway activity (34) (Fig. 3). Hygromycin B is an aminoglycoside antibiotic that inhibits the growth of many yeast mutants with defects in N glycosylation (17) and has been used to probe cell wall integrity in cell wall mutants (7, 10, 63). As a test of the relevance of MOG1 to the SLN1-SKN7 pathway, we examined the effect of mog1
on hygromycin resistance. As shown in Fig. 3, deletion of MOG1 caused sensitivity to hygromycin B at 28°C. These results are consistent with an involvement of Mog1p in SLN1-SKN7 signal transduction. Another skn7 mutant phenotype, sensitivity to oxidative stress (30), is not mimicked in the mog1 mutant. Growth of the mog1
strain on 0.5 mM t-butyl-hydroperoxide was comparable to the growth of an isogenic wild-type strain on the same medium (Fig. 3). Since the oxidative stress phenotype of skn7 mutants reflects the role of Skn7p in a SLN1-independent pathway, these results suggest that Mog1p specifically affects the SLN1-SKN7 pathway and not Skn7p function in general.
|
|
To gain further insight into the basis of the Mog1p interaction with Skn7p, we examined the features of Skn7p required for the interaction. Western analysis confirmed that each Skn7p derivative was expressed at equivalent levels (Fig. 5A, lanes 9 to 12, and B, lanes 7 to 9). The interaction between Mog1p and Skn7p does not require the DNA-binding domain of Skn7p (Fig. 5A, lane 4). The Mog1p-Skn7p interaction also showed no detectable dependence on Skn7 aspartyl phosphorylation. A Skn7p derivative in which aspartate D427 was mutated to asparagine (D427N), thus rendering the Skn7 receiver domain unable to accept a phosphoryl group from upstream SLN1 pathway components, interacted as well with Mog1p as did wild-type Skn7p (Fig. 5A, lanes 1 and 2). Likewise, the D427E derivative of SKN7, which results in constitutive activation of SLN1-SKN7 targets, did not alter the interaction with Mog1p (Fig. 5A, lanes 1 and 3). To localize the domain of Skn7p required for the interaction, derivatives of Skn7, expressing the N terminus, the middle, or the C terminus of the protein and fused to GFP, were used in coprecipitation assays with GST-Mog1p. The construct consisting of the "middle" of Skn7p (including the CC and receiver domains) interacted most strongly with Mog1p (Fig. 5B), whereas the N-terminal construct (including the DBD and CC domains) did not interact at all. A weak interaction was detected with the C-terminal construct (including the receiver and glutamine-rich domains). These data indicate that the Mog1p interaction with Skn7p requires the receiver domain and may be enhanced by the presence of the coiled-coil domain.
|
strains. Localization was examined at 28°C and at times after a shift to 37°C. Skn7p-GFP was nuclear at both low and high temperatures in the MOG1+ strain (Fig. 6A). Incubation of the mog1 mutant at the elevated temperature, however, caused a change in the nuclear localization of Skn7p. After 1 h at 37°C, cells could be detected in which Skn7p-GFP was distributed throughout the cytoplasm, as well as the nucleus (Fig. 6A). In contrast, the normal localization of Ypd1p-GFP in both the cytoplasmic and nuclear compartments (36) was not detectably altered by the mog1 mutation (Fig. 6B). These results reveal a requirement for functional Mog1 protein in Skn7p nuclear import. Since, as expected (45), there were no detectable localization defects at 28°C, the hygromycin sensitivity and SLN1-SKN7 signaling defects in the mog1 mutant at this temperature must reflect a Mog1p function in SLN1-SKN7 signal transduction that is distinct from its role in protein trafficking.
|
extracts expressing Skn7-HA. The absence of Mog1p appeared to have no effect on Skn7p association with Ypd1p (Fig. 7). A possible contribution of Mog1p to Sln1p-, Ypd1p-, and Skn7p-dependent phosphotransfer steps was also investigated. The efficiency of each phosphotransfer reaction was evaluated in the presence or absence of bacterially purified Mog1p. The presence of Mog1p in the reaction appeared to have subtle effects on the Sln1 kinase to Sln1 receiver phosphotransfer, slightly increasing the rate of receiver domain phosphorylation (Fig. 8A) . Although reproducible, this and other modest effects seen in vitro may or may not occur in vivo and seem unlikely to account for the mog1
phenotypes.
|
|
SKN7 extracts and well-characterized fragments containing Skn7p binding sites from the OCH1 or TRX2 promoters. Since oxidative stress resistance (Fig. 3) was unaffected in the mog1
mutant, the TRX2 fragment was included as a negative control. The absence of Mog1p caused a reduction in Skn7p binding to the OCH1 promoter (mog1
/MOG1 = 0.57, n = 11) but had no effect on binding to the TRX2 promoter (mog1
/MOG1 = 1.01, n = 10) (Fig. 9A). Antibody supershift assays were performed to examine the possibility that Mog1p is associated with the Skn7p-DNA complex. Extracts prepared from strains carrying a functional MOG1-myc allele were used in DNA-binding reactions with OCH1 or TRX2 promoter fragments and an increasing concentration of
-myc antibody (Fig. 9B).
-Skn7p antibody was used in parallel as a control. The addition of increasing concentration of Skn7p antibody caused the OCH1 complex to migrate progressively slower (Fig. 9B, lanes 1 to 4) (34). A supershift of the OCH1-Skn7p complex was also observed with
-myc antibody (Fig. 9B, lanes 5 to 8), suggesting that Mog1p is present in the complex. Identical concentrations of
-myc antibody failed to cause such a shift in control reactions involving extracts prepared from untagged Mog1p (Fig. 9B, lanes 9 to 12) and also had no effect on the complex of Skn7p with the TRX2 promoter (Fig. 9B, lanes 13 to 17). These studies suggest that Mog1p is specifically associated with Skn7p on SLN1-regulated, SKN7-dependent promoters and that one role of the Mog1 protein is in facilitating Skn7p association with the promoters of osmotic stress target genes.
|
| DISCUSSION |
|---|
|
|
|---|
strain demonstrated that Mog1p is required for nuclear import in vivo (45). Our studies reveal a novel function for Mog1p in regulating the stress activated transcription factor, Skn7p.
That the role of Mog1p in regulating Skn7p activity is separate from its known role in nucleocytoplasmic transport is supported by the observation that the mog1
mutant exhibits defects in Skn7p signaling even at temperatures permissive for localization. Strains lacking MOG1 exhibit a temperature-dependent defect in NLS-dependent and NLS-independent protein import pathways (45). The function of Mog1p in protein localization is essential at the elevated temperature since the mog1 deletion mutant is also temperature sensitive for growth. The synthetic lethality of a mog1 prp20-1 double mutant at the permissive temperature (5) suggests that Mog1p may have overlapping functions with the yeast Ran guanine nucleotide exchange factor, Prp20p.
Since both NLS-dependent and NLS-independent nuclear localization are impaired in mog1 deletions at high temperatures, the mislocalization of Skn7p at the elevated temperature was expected. What was surprising was that, despite the absence of detectable localization defects at the permissive temperature, the mog1 deletion strain nonetheless exhibited a reduction in activation of SLN1-SKN7 target genes and a hygromycin-sensitive phenotype similar to that seen in skn7 mutants. These are the first reports of mog1
phenotypes at the permissive temperature.
The Mog1p interaction with Gsp1p requires amino acids 30 to 70 on the Mog1p surface. These residues are conserved in all Mog1p homologs, and mutations of Asp62 and Glu65 cause defects in nuclear protein import (6, 56). Since the Mog1p fusion recovered in our two-hybrid screen started at amino acid 78, the interactions between Mog1p and components of the SLN1-SKN7 pathway appear to require a distinct surface of Mog1p. The separate interactions of Mog1p with the nuclear transport machinery and with proteins such as Skn7p that might constitute cargo are consistent with a direct role for Mog1p in nuclear localization.
Since the interaction between Mog1p and each protein that might potentially be in a SLN1-SKN7 signalosome was independent of each of the others, it is clear that Mog1p is capable of separately, if not simultaneously, interacting with each protein. In this respect, Mog1p appears to share some features with scaffold proteins, such as Ste5p and Pbs2p, which associate physically with various components of the pheromone and osmotic response MAP kinase pathways, respectively (15, 39, 49). Like other scaffolds, Mog1p associates with a membrane-associated sensor (Sln1p), as well as with downstream components that regulate the activity of effectors (20). Furthermore, the proposal that the Ste5p scaffold facilitates phosphorylation (20) provides a paradigm for thinking about potential roles for Mog1p in stimulating SLN1-SKN7 pathway activity.
The mog1 defects reported here reflect a specific role of Mog1p in SLN1-SKN7 signal transduction, as opposed to a more general role for Mog1p in all aspects of SLN1 signal transduction. The observation that mog1 mutants are not salt sensitive (J. M.-Y. Lu and J. S. Fassler, unpublished results) indicates that SLN1-HOG1 signaling is intact. Likewise, the absence of an oxidative-stress-sensitive phenotype in the mog1 mutant (Fig. 3) is consistent with the conclusion that Mog1p is not needed for Skn7p activation of oxidative stress response genes. Whether Mog1p has a special relationship with molecules in the SLN1-SKN7 pathway or whether it might function in additional signal transduction pathways whose activities have not been assayed here remains an open question.
In conclusion, Mog1p is required for optimal binding of Skn7p to the promoter of the SLN1-SKN7-dependent target gene OCH1. Moreover, antibody supershift experiments show that Mog1p is part of the Skn7p-OCH1 complex. Interestingly, the mobility of Skn7p complexes was not influenced by the presence or absence of Mog1p, perhaps due to the small size of the Mog1 protein. Examples of DNA-associated proteins whose absence causes no detectable change in the mobility of a complex have been reported (9).
The presence of Mog1p in the Skn7p complex is unlikely to be a reflection of intrinsic DNA-binding activity in Mog1p. The Mog1 protein bears no detectable similarity to known DNA-binding domains, nor have we detected complexes consisting of Mog1p alone in gel shift assays. More likely is that Mog1p association with Skn7p is a reflection of the involvement of Mog1p in a coactivator complex involved in recruitment of RNA polymerase and the general transcriptional machinery. This model is consistent with the growing body of evidence for connections between translocation machinery and regulation of transcription (13, 27).
Our observations of Mog1p function in the SLN1-SKN7 osmotic stress signal transduction pathway in S. cerevisiae provides a new perspective for understanding the global activities of the Mog1 protein in yeast and, given the ubiquitous presence of Mog1p homologs in eukaryotes ranging from yeast to humans (40, 44, 61), in other organisms as well. Prior reports of a specific interaction between the Ran binding protein, RanBPM with the androgen receptor/transcription factor (51) bears some similarity to our findings of a Mog1p-Skn7p interaction. We speculate that Ran binding proteins such as RanBPM and Mog1 may constitute a new class of bifunctional proteins with roles in nucleocytoplasmic transport, as well as in the recruitment of transcription factors to specific promoters.
| ACKNOWLEDGMENTS |
|---|
strain, Anna De Antoni (European Institute of Oncology) for providing plasmids for integrative epitope tagging, and Lee Johnston and coworkers (National Institute for Medical Research, London, United Kingdom) for generously providing the
-Skn7 antibody. This study was supported by grant GM56719 from the National Institutes of Health and an American Heart Association Postdoctoral Fellowship to J.M.-Y.L.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
1 protein, a yeast transcription activator, binds synergistically with a second protein to a set of cell type-specific genes. Cell 50:681-691.[CrossRef][Medline]